Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells.
about
Minnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivoTriptolide induces cell-cycle arrest and apoptosis of human multiple myeloma cells in vitro via altering expression of histone demethylase LSD1 and JMJD2B.Effects of triptolide on RIZ1 expression, proliferation, and apoptosis in multiple myeloma U266 cellsGenome-wide association analysis identified splicing single nucleotide polymorphism in CFLAR predictive of triptolide chemo-sensitivity.MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid MalignanciesHerbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase.Triptolide avoids cisplatin resistance and induces apoptosis via the reactive oxygen species/nuclear factor-κB pathway in SKOV3(PT) platinum-resistant human ovarian cancer cells.An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo.Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.Triptolide exerts pro-apoptotic and cell cycle arrest activity on drug-resistant human lung cancer A549/Taxol cells via modulation of MAPK and PI3K/Akt signaling pathways.Anti-cancer and Sensibilisation Effect of Triptolide on Human Epithelial Ovarian Cancer.Triptolide and management of systemic malignancies besides pancreatic carcinomas.HSPA12B overexpression induces cisplatin resistance in non-small-cell lung cancer by regulating the PI3K/Akt/NF-κB signaling pathway.Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells
P2860
Q27303920-172BEA08-7159-423A-8C0F-FE26BA4B2146Q33567000-9F795620-2169-471B-9AE0-E1903A630BE9Q33593796-8FE55CE3-C0DB-4367-A3DE-4A20D0CB6B1AQ35677567-EDC292C8-FE0D-422C-ABA3-5D2116A1809FQ36602853-44452325-9C91-45F8-A548-9B560DCEB6D2Q37057176-5F1FD84A-0601-4193-9AEE-8DD888B93C53Q37229429-8D90434A-A636-49E5-8CC9-C1A4DD7897BAQ37320140-0119F741-D127-46B9-B5F4-1CFD5433766EQ37333773-F8C765FF-7EBD-420B-A0B4-4C10953EC484Q37407088-4B28CA35-920C-41A1-AF74-D83646A0385EQ37427962-1D7A880E-C37D-4FCF-B466-945804F65CF3Q42575784-4B454DEE-A899-44BD-AF54-5CD026DC6C1BQ53700825-76B93D16-21AA-4786-B289-B4814143A65AQ58777919-0902EA15-A0CA-4171-A573-80602BEE1410
P2860
Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Triptolide overcomes dexametha ...... human multiple myeloma cells.
@en
Triptolide overcomes dexametha ...... human multiple myeloma cells.
@nl
type
label
Triptolide overcomes dexametha ...... human multiple myeloma cells.
@en
Triptolide overcomes dexametha ...... human multiple myeloma cells.
@nl
prefLabel
Triptolide overcomes dexametha ...... human multiple myeloma cells.
@en
Triptolide overcomes dexametha ...... human multiple myeloma cells.
@nl
P2093
P1476
Triptolide overcomes dexametha ...... n human multiple myeloma cells
@en
P2093
P304
P577
2008-10-01T00:00:00Z